Edwards Lifesciences (NYSE:EW) will report earnings after markets close on Thursday, July 25th. Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
Here is your Cheat Sheet to Edwards Lifesciences Earnings:
Earnings Expectations: Analysts expect earnings of $0.76 per share on revenues of $514.76 million. Currently, the company’s P/E ratio stands at 21.19.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.76 to a profit $0.72. For the current year, the average estimate is a profit of $3.06, which is worse than the estimate ninety days ago.
Here’s how Edwards Lifesciences has been performing on an annual basis:
|Revenue ($) in millions||1,238||1,321||1,447||1,679||1,900|
|Diluted EPS ($)||1.10||1.95||1.83||1.98||2.48|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||482.00||447.90||510.50||496.70|
|Diluted EPS ($)||0.57||0.58||0.77||1.24|
Edwards Lifesciences has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)